NTRK2 and Parkinson disease: 7,8-DHF acts as a selective and efficient TrkB agonist and presents neuroprotective effects in excitotoxic processes induced in vitro [199] or using in vivo models of brain ischemia [198], AD [200], ALS [201] or PD [198], among others.